ArticlePharmacological research2019

NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.

Rebecca Ward et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.